This site became the new ClinicalTrials.gov on June 19th. Learn more.
Show more
ClinicalTrials.gov Menu IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
ClinicalTrials.gov Menu IMPORTANT: Talk with a trusted healthcare professional before volunteering for a study. Read more...
ClinicalTrials.gov Menu
Give us feedback

Proton Therapy vs. IMRT for Low or Intermediate Risk Prostate Cancer (PARTIQoL)

This study is currently recruiting participants.
See Contacts and Locations
Verified July 2017 by Jason Efstathiou, Massachusetts General Hospital
Sponsor:
Collaborators:
University of Pennsylvania
National Cancer Institute (NCI)
Northwestern University
ProCure Proton Therapy Center
Washington University School of Medicine
University of Washington
Memorial Sloan Kettering Cancer Center
Rutgers Cancer Institute of New Jersey
Provision Center for Proton Therapy
Mayo Clinic
University of Maryland
Information provided by (Responsible Party):
Jason Efstathiou, Massachusetts General Hospital
ClinicalTrials.gov Identifier:
NCT01617161
First received: June 8, 2012
Last updated: July 19, 2017
Last verified: July 2017
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: December 2026
  Estimated Primary Completion Date: December 2018 (Final data collection date for primary outcome measure)